Will the Hard Times For Bio-Tech Companies Continue?

2 posts / 0 new
Last post
samrtconsulting's picture
Will the Hard Times For Bio-Tech Companies Continue?

 As the economic downturn continues to run rampant, not only in the United States, but all over the world, it is no surprise that the Biotechnology and Pharmaceutical industries are taking a hit as well.  However, a recent disturbing trend has shown that the Bio-Tech industry seems to be more susceptible than most had previously thought.  Because of the high cost of production and research in the Bio-tech industry, many companies don’t know how they will manage to survive much longer.  And as this economic recession continues to barrel on with no end in sight, many Bio-tech companies are just hoping that they will still be in business when it is all over.
Among the many large industries being affected by this economic recession, the Bio-Tech industry is particularly vulnerable.  It is not uncommon, in the Bio-Tech industry, for years to go by without receiving any kind of new revenue, as well as just have a little operating capital left in the bank to survive.  In the past, when the market was better, this wouldn’t be wholly unlikely.  If a drug company was showing signs of progress or if they had a promising new drug in development, it wouldn’t be surprising for it to get flooded with investment capital, to start larger, more lucrative projects.  But, regrettably, this is no longer the case.  Since the economic downturn started showing its ghastly effects last year, fewer people have been investing, and investment capital is becoming ever scarcer. 
However, over the past few weeks things are starting to look up for the Pharmaceutical industry. As the stock market begins to rally, some larger Bio-tech companies are seeing big gains, and even bigger investments.  Take over rumors are prevalent, as stock prices are beginning to rise.  Some life sciences consulting firms are even projecting that the Bio-Tech industry could even make a full recovery within the next 5 years.  However, not everyone is so optimistic.
In the first half of 2008 the Bio-tech industry raised more than 8.3 billion dollars, until the recession hit.  However, this year they have only been able to raise about 6 billion.  Investment capital is down, as well as government assistance.  But this could all be subject to change.  With the recent Swine Flu concern many Bio-tech companies are clamoring to get a piece of these high valued government contracts, which could be worth tens of billions of dollars.  As the flu season approaches, and as stocks continue to rise, pharmaceutical consultancy  firms believe the Bio-Tech industry could very well have put the worst of it behind them.
If you liked this article, tell all your friends about it. They’ll thank you for it. If you have a blog or website, you can link to it or even post it to your own site (don’t forget to mention Smart Consulting Group as the original source).
Rachel Clarkson
pharmaceutical consultants

Chuck_Yuan's picture
Unfortunately, in my personal

Unfortunately, in my personal investing, I have found that investing in the Bio-Tech industry does not counter-act the decline of the Dollar. As with any investment these days, that is my main concern. I have found that only gold truly counter-acts the decline of the U.S. Dollar. Since the Euro was established, although it is only back by gold 15%, it has by far outperformed the U.S. Dollar and, since the U.S. Dollar is not backed by gold, it has lost it's value and continues to lose its value. So far, the only investment I have found to truly counter-act the fall of the Dollar is by literally backing yourself with coins. To be specific, U.S., investment-grade gold and silver coins, so it's not just the weight of the coin, but also the collector's or "rarity" value. In other words, bullion's value is based on it's weight alone, whereas investment-grade gold and silver coins derive their value from their rarity value, in addition to their weight. Lastly, the primary reason to look at coins as an investment is their privacy level, because no one has to know that you have them. They are not reportable, either, as most other investments. I highly recommend the experts at Gold Run Investments for expert advice as well as the best pricing structure. For more information, go to GoldRunInvestments.com.